Research progress of long non-coding RNA UCA1 in tumor

Abstract

Shi Youyang, Qian Yayun. Research progress of long non-coding RNA UCA1 in tumor[J]. Journal of International Oncology, 2016, 43(1): 29-31.

［1］ Wang XS, Zhang Z, Wang HC, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladdercarcinoma［J］. Clin Cancer Res, 2006, 12 (16): 4851-4858. DOI:10.1158/10780432.CCR-06-0134. ［2］ Xue M, Li X, Wu W, et al. Upregulation of long noncoding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis［J］. Oncol Rep, 2014, 31(5): 1993-2000. DOI:10.3892/or.2014.3092. ［3］ Xie XJ, Li X, Wang F, et al. Cellular localization and tissue expression pattern of UCA1, a noncoding RNA［J］. Nan Fang Yi Ke DaXue Xue Bao, 2010, 30(1): 57-60. ［4］ Rafiee P, Shi Y, Su J, et al. Erythropoietin protects the infant heart against ischemiareperfusion injury by triggering multiple signaling pathways［J］. Basic Res Cardiol, 2005, 100(3): 187-197. ［5］ Codolo G, Munari F, Fassan M, et al. Evaluation of the efficacy of the H. pylori protein HPNAP as a therapeutic tool for treatment of bladder cancer in an orthotopic murine model［J］. J Vis Exp, 2015, 99: e52743. DOI:10.3791/52743. ［6］ Zhang Z, Hao H, Zhang CJ, et al. Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder［J］. Zhonghua Yi Xue Za Zhi, 2012, 92(6): 384-387. ［7］ Wang F, Li X, Xie X, et al. UCA1, a nonproteincoding RNA upregulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion［J］. FEBS Letters, 2008, 582(13): 1919-1927. DOI:10.1016/j.febslet.2008.05.012. ［8］ Fan Y, Shen B, Tan M, et al. Long noncoding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling［J］. FEBS J, 2014, 281(7): 1750-1758. DOI:10.1111/febs.12737. ［9］ Yang C, Li X, Wang Y, et al. Long noncoding RNA UCA1 regulated cell cycle distribution via CREB through PI3K dependent pathway in bladder carcinoma cells［J］. Gene, 2012, 496(1): 8-16. DOI:10.1016/j.gene.2012.01.012. ［10］ Wang X, Gong X, Jin B, et al. Long noncoding RNA urothelial carcinoma associated 1 induces cell replication by inhibiting BRG1 in 5637 cells［J］. Oncology Rep, 2014, 32(3): 1281-1290. DOI:10.3892/or.2014.3309. ［11］ Gu W, Gao T, Sun Y, et al. LncRNA expression profile reveals the potential role of lncRNAs in gastric carcinogenesis［J］. Cancer Biomark, 2015, 15(3): 249-258. DOI:10.3233/CBM-150460. ［12］ Han Y, Yang YN, Yuan HH, et al. UCA1, a long noncoding RNA upregulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution［J］. Pathology, 2014, 46(5): 396-401. DOI:10.1097/PAT.0000000000000125. ［13］ Li JY, Ma X, Zhang CB. Overexpression of long noncoding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma［J］. Int J Clin Exp Pathol, 2014, 7(11): 7938-7944. ［14］ Huang J, Zhou N, Watabe K, et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1)［J］. Cell Death Dis, 2014, 5：e1008. DOI:10.1038/cddis.2013.541. ［15］杨慧, 余敏敏, 陆晓媛. 长链非编码RNA在宫颈癌及宫颈上皮内瘤样病变中的表达［J］. 江苏医药, 2014, 40(22): 2685-2688. ［16］ Lim D, Olive E. Precursors and pathogenesis of ovarian carcinoma［J］. Pathology, 2013, 45(3): 229-242. DOI:10.1097/PAT.0b013e32835f2264. ［17］ Wang F, Zhou J, Xie X, et al. Involvement of SRPK1 in cisplatin resistance related to long noncoding RNA UCA1 in human ovarian cancer cells［J］. Neoplasma, 2015, 62(3): 432-438. DOI:10.4149/neo/2015/051. ［18］ Gerstner ER, Batchelor TT. Imaging and response criteria in gliomas［J］. Curr Opin Oncol, 2010, 22(6): 598-603. DOI:10.1097/CCO.0b013e32833de96e. ［19］孙阳. 长链非编码RNA在脑胶质瘤中差异表达的相关研究［D］. 长春: 吉林大学, 2014. ［20］ Tsang WP, Wong TW, Cheung AH, et al. Induction of drug resistance and transformation in human cancer cells by the noncodingRNA CUDR［J］. RNA, 2007, 13(6): 890-898. DOI:10.1261/rna.359007. ［21］ Tian Y, Zhang X, Hao Y, et al. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma[J]. Melanoma Res, 2014, 24(4): 335-341. DOI:10.1097/CMR.0000000000000080. ［22］ Fang Z, Wu L, Wang L, et al. Increased expression of the long noncoding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis［J］. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(1): 8995. DOI:10.1016/j.oooo.2013.09.007.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Research progress of long non-coding RNA UCA1 in tumor

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments